Truist Securities analyst Jailendra Singh maintains Accolade (NASDAQ:ACCD) with a Buy and raises the price target from $15 to $16.
Truist Securities Maintains Buy on Accolade, Raises Price Target to $16-Report Released on 8 January 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.